UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000006539
Receipt No. R000007750
Official scientific title of the study Trail against hyperlipidemia patients with high risks to investigate the effect on small dense LDL-C & IDL by using middle dose Rosuvastatin in Saitama
Date of disclosure of the study information 2011/11/07
Last modified on 2017/09/27 (Ver. 7)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Trail against hyperlipidemia patients with high risks to investigate the effect on small dense LDL-C & IDL by using middle dose Rosuvastatin in Saitama
Title of the study (Brief title) PIONEER Saitama
Region
Japan

Condition
Condition Hyperlipidemia
Classification by specialty
Endocrinology and Metabolism
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The lipid medical treatment by rosuvastatin to a high risk hyperlipidemia patient examines propriety aiming at disappearance of small dense LDL and IDL. The patients were estimated in 120 patients receiving coronary computed tomographic angiography (CCTA).
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Lipid profile (TC,TG,HDL-C, Friedewald LDL-C,small dense LDL,IDL),apo protein, apoE phenotype
Key secondary outcomes Cr, BUN, Urinal analysis, GOT, GPT, CK, (following in the case of DM), fasting blood glucose, HbA1c. The coronary computed tomographic angiography (CCTA) was repeated and compared before and after treatment.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Rosuvastatin 5mg-20mg for 6 month
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
15 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)-3) 3 examine group
1)T2DM with 120 mg/dl or more than 120 mg/dl LDL-C
2)Patients of JAS Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2007 CategoryIII (Diabetes patients are excepted) with 120 mg/dl or more than 120 mg/dl LDL-C
3)Patients of JAS Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2007 Secondary prevention with 100 mg/dl or more than 100 mg/dl LDL-C
Key exclusion criteria A patient with the side-effects past in statin medication
Target sample size 200

Research contact person
Name of lead principal investigator Ikuo Inoue
Organization Saitama Medical University
Division name Dept. of Endocrinology and Diabetology
Address 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama
TEL 049-276-1875
Email i1901018@saitama-med.ac.jp

Public contact
Name of contact person Ikuo Inoue
Organization Saitama Medical University
Division name Dept. of Endocrinology and Diabetology
Address 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama
TEL 049-276-1875
Homepage URL
Email i1901018@saitama-med.ac.jp

Sponsor
Institute Ikuo Inoue
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2011 Year 11 Month 07 Day

Progress
Recruitment status Completed
Date of protocol fixation
2011 Year 11 Month 07 Day
Anticipated trial start date
2011 Year 11 Month 01 Day
Last follow-up date
2012 Year 12 Month 01 Day
Date of closure to data entry
2013 Year 12 Month 01 Day
Date trial data considered complete
2013 Year 12 Month 01 Day
Date analysis concluded
2014 Year 12 Month 01 Day

Related information
URL releasing protocol
Publication of results Partially published
URL releasing results
Results
Other related information

Management information
Registered date
2011 Year 10 Month 13 Day
Last modified on
2017 Year 09 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007750